Rs 75 Dividend Declared: Healthcare stock surge 14% post Q4 results

Rs 75 Dividend Declared: Shares of Sanofi Consumer Healthcare India rallied sharply on Thursday after the company reported strong December quarter earnings and announced a final dividend.

The stock climbed as much as 16.4 per cent to an intraday high of Rs 4,694.80 on the NSE. At around 12:24 pm, it was trading at Rs 4,664.10, up Rs 654.90 or 16.33 per cent.

The scrip has gained 16 per cent in the past week and 14 per cent over the last one month. On a year-to-date basis, it is up 2.25 per cent. The stock had touched a 52-week low of Rs 3,975 on February 24, 2026, while its 52-week high stands at Rs 5,894.50, hit on June 30, 2025.

Add Zee Business as a Preferred Source

Sanofi Consumer Healthcare India has a market capitalisation of Rs 10,624.95 crore, according to NSE data as of February 26, 2026.

Q4 profit rises 50 per cent

The consumer healthcare company reported a 50.11 per cent year-on-year rise in net profit to Rs 66.5 crore for the fourth quarter of calendar year 2025. It had posted a profit of Rs 44.3 crore in the same period last year, according to a regulatory filing dated February 25.

Revenue from operations jumped 47.04 per cent year-on-year to Rs 251 crore in Q4 CY25, compared with Rs 170.7 crore in Q4 CY24.

Domestic sales grew 23 per cent, aided by the relaunch of recalled products in the market. Export sales surged 9.3 times on a low base.

Full-year performance remains strong

For calendar year 2025, revenue rose 21 per cent year-on-year to Rs 878.4 crore.

Profit after tax for CY25 increased 33 per cent to Rs 240.1 crore, supported by cost discipline and improved product mix.

Domestic sales grew 7 per cent during the year, while export sales jumped 158 per cent.

Final dividend of Rs 75 per share

The board has recommended a final dividend of Rs 75 per equity share of face value Rs 10 each for FY25, subject to shareholder approval at the upcoming annual general meeting.

The company said it will announce the record date and book closure details in due course.

Management commentary

Himanshu Bakshi, Managing Director, said the quarter underlined the strength of the company’s core portfolio and disciplined execution. He noted that the domestic business delivered healthy double-digit growth for two consecutive quarters, supported by exports.

Amit Jain, Chairman, said the full-year performance reflected strong strategy execution and enabled the company to reward shareholders with a healthy dividend.